You are here: Home 
Categories Prostate Cancer
Categories Prostate Cancer Pilot phase II trial of bevacizumab monotherapy in nonmetastatic castrate-resistant prostate cancer - Abstract
Pilot phase II trial of bevacizumab monotherapy in nonmetastatic castrate-resistant prostate cancer - Abstract
Published on 10 August 2012
Background: Nonmetastatic castrate resistant prostate cancer (CRPC) is a challenging disease state.
To read more, a FREE Urotoday registration is required. Click here to register or login above.To read UIJ content, a separate subscription is required.
Tags:
